Current Appointments & Affiliations
Associate Professor of Pathology
·
2021 - Present
Pathology,
Clinical Science Departments
Recent Publications
Conventional Cytogenetic Analysis of Solid Tumor Abnormalities: A 25-Year Review of Proficiency Test Results from the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee.
Journal Article Genes (Basel) · December 17, 2024 Background: The joint College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee works to ensure the competency and proficiency of clinical cytogenetic testing laboratories through proficiency testing (PT) pro ... Full text Link to item CiteSequential Development of JAK2V617F Mutation and BCR-ABL1 Fusion in Individual Patients With Myeloproliferative Neoplasms.
Journal Article Arch Pathol Lab Med · June 1, 2022 CONTEXT.—: Concomitant BCR-ABL1 and JAK2V617F in myeloproliferative neoplasms (MPNs) is rare, and its pathogenesis and clinical significance are unclear. OBJECTIVE.—: To investigate the clonal relationship between the 2 genomic alterations, as well as the ... Full text Link to item CiteChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Secondary Acquisition of t(11;14)(q13;q32)/CCND1-IGH: A Rare Variant Of Richter Transformation to Mantle Cell Lymphoma.
Journal Article Clin Lymphoma Myeloma Leuk · May 2022 INTRODUCTION: Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) occasionally undergoes Richter transformation, mostly to diffuse large B-cell lymphoma, but its evolution to other types of B-cell lymphoma is rare. We report a CLL evolved to ... Full text Link to item CiteRecent Grants
Developing strategies to identify candidate individuals for early genetic therapies
ResearchCollaborator · Awarded by National Institutes of Health · 2024 - 2029Functional characterization and reclassification of Pompe disease variants of uncertain significance (VUS) in carefully phenotyped patients: an approach towards high-throughput screening
ResearchCo-Chair · Awarded by Amicus Therapeutics Corporation · 2023 - 2025COG Senior Cytogenetics Reviewer
ResearchPrincipal Investigator · Awarded by Public Health Institute · 2024 - 2025View All Grants
Education, Training & Certifications
Virginia Commonwealth University ·
2004
Ph.D.
North Carolina State University ·
1999
B.A.